Abstract
Arthropod-borne viruses, also known as arboviruses, are transmitted by bites of infected mosquito or tick vectors. In this context, the Flavivirus genus is mainly transmitted by mosquitoes from the Aedes genus, being the Ae. africanus, Ae. aegypti, and Ae. Albopictus species are responsible for transmitting the Zika virus (ZIKV). It is a lipid-enveloped virus constitute of an RNA genome, which is translated into a polyprotein encoding three structural proteins {(capsid (C), membrane (M), and envelope (E)} and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5). Several biological targets have been identified for developing antiviral agents against ZIKV, which could prevent virus entry, assembly, or release of new virion particles, by interactions with structural proteins. Drugs targeting non-structural proteins could inhibit the ZIKV-replication cycle. Nature has provided excellent compounds for designing new potent analogs. The medicinal chemistry emerges as an impressive, rationally design and to develop new antiviral agents. Additionally, virtual and high-throughput screenings have contributed greatly to the identification of previously approved-drugs that could be repurposed for ZIKV, as antiviral agents. In this chapter, we offer a literature review about the most relevant and recent advances made on the medicinal chemistry of ZIKV research. We focus on natural, nature-based, semi-synthetic, and synthetic antiviral compounds, as well as repurposed drugs and other inhibitors targeting ZIKV.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aagaard KM, Lahon A, Suter MA, Arya RP, Seferovic MD, Vogt MB, Hu M, et al. Primary human placental trophoblasts are permissive for Zika virus (ZIKV) replication. Sci Rep. 2017. https://doi.org/10.1038/srep41389.
Abdel-Hady M, Bansal S, Davison SM, Brown M, Tizzard SA, Mulla S, Barnes E, Davies P, Mieli-Vergani G, Kelly DA. Treatment of chronic viral hepatitis C in children and adolescents: UK experience. Arch Dis Child. 2014;99(6):505–10. https://doi.org/10.1136/archdischild-2013-304601.
Adcock RS, Chu Y-K, Golden JE, Chung D-H. Evaluation of anti-Zika virus activities of broad-spectrum antivirals and NIH clinical collection compounds using a cell-based, high-throughput screen assay. Antiviral Res. 2017;138:47–56.
Akaberi D, Chinthakindi PK, Båhlström A, Palanisamy N, Sandström A, Lundkvist Å, Lennerstrand J. Identification of a C2-symmetric diol based human immunodeficiency virus protease inhibitor targeting Zika virus NS2B-NS3 protease. J Biomol Struct Dyn. 2019;1102. https://doi.org/10.1080/07391102.2019.1704882.
Andral L, Brès P, Sérié C, Casals J, Panthier R. Studies on yellow fever in ethiopia. 3. Serological and virological studies of the woodland fauna. Bull World Health Organ. 1968.
Anggakusuma CC, Colpitts LM, Schang HR, Frentzen A, Pfaender S, Behrendt P, et al. Turmeric curcumin inhibits entry of all hepatitis C virus genotypes into human liver cells. Hepatology. 2014;63:1137–49. https://doi.org/10.1136/gutjnl-2012-304299.
de Araújo TVB, Rodrigues LC, de Alencar Ximenes RA, de Barros Miranda-Filho D, Montarroyos UR, de Melo APL, Valongueiro S, et al. Association between Zika virus infection and microcephaly in Brazil, January to May, 2016: preliminary report of a case-control study. Lancet Infect Dis. 2016;16(12):1356–63. https://doi.org/10.1016/S1473-3099(16)30318-8.
Ashwal S, Michelson D, Plawner L, Dobyns WB. Practice parameter: evaluation of the child with microcephaly (an evidence-based review): report of the quality standards subcommittee of the American academy of neurology and the practice committee of the child neurology society. Neurology. 2009. https://doi.org/10.1212/WNL.0b013e3181b783f7.
Assuncao-Miranda I, Cruz-Oliveira C, Neris RLS, Figueiredo CM, Pereira LPS, Rodrigues D, Araujo DFF, Da Poian AT, Bozza MT. Inactivation of dengue and yellow fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX. Appl Microbiol. 2016;120:780–804. https://doi.org/10.1111/jam.13038.
Babitt JL, Huang FW, Wrighting DM, Xia Y, Sidis Y, Samad TA, Campagna JA, et al. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat Genet. 2006;38(5):531–9. https://doi.org/10.1038/ng1777.
Balasubramanian A, Teramoto T, Kulkarni AA, Bhattacharjee AK, Padmanabhan R. Antiviral activities of selected antimalarials against dengue virus type 2 and Zika virus. Antivir Res. 2017;137. Elsevier Ltd. https://doi.org/10.1016/j.antiviral.2016.11.015.
Barbés C, Sanchez J, Yebra MJ, Robert-Géro M, Hardisson C. Effects of sinefungin and S-adenosylhomocysteine on DNA and protein methyltransferases from streptomyces and other bacteria. FEMS Microbiol Lett. 1990;69:239–44.
Barbosa-Lima G, da Silveira LS, Pinto CR, Kaiser JL, Wardell CS, Freitas De, Vieira YR, Marttorelli A, et al. N-(2-(arylmethylimino)ethyl)-7-chloroquinolin-4-amine derivatives, synthesized by thermal and ultrasonic means, are endowed with anti-Zika virus activity. Eur J Med Chem. 2017;127:434–41. https://doi.org/10.1016/j.ejmech.2017.01.007.
Barras A, Pagneux Q, Sane F, Wang Qi, Boukherroub R, Hober D, Szunerits S. High efficiency of functional carbon nanodots as entry inhibitors of herpes simplex virus type 1. ACS Appl Mater Interfaces. 2016;8(14):9004–13. https://doi.org/10.1021/acsami.6b01681.
Barrows NJ, Campos RK, Steven Powell K, Prasanth R, Schott-lerner G, Soto-acosta R, Galarza-muñoz G, et al. A screen of FDA-approved drugs for inhibitors of Zika virus infection. Cell Host Microbe. 2017;20(2):259–70. https://doi.org/10.1016/j.chom.2016.07.004.A.
Barrows NJ, Campos RK, Powell ST, Routh A, Bradrick SS, Garcia-blanco MA, Barrows NJ, et al. Resource a screen of FDA-approved drugs for inhibitors of Zika virus infection resource a screen of FDA-approved drugs for inhibitors of Zika virus infection. 2016;259–70.
Basic M, Elgner F, Bender D, Sabino C, Herrlein M-L, Roth H, Glitscher M, et al. A synthetic derivative of houttuynoid B prevents cell entry of Zika virus. Antivir Res. 2019;172(June):104644.
Bhargava S, Patel T, Gaikwad R, Patil UK, Gayen S. Identification of structural requirements and prediction of inhibitory activity of natural flavonoids against Zika virus through molecular docking and Monte Carlo based QSAR simulation. Nat Prod Res. 2019;33(6):851–7. https://doi.org/10.1080/14786419.2017.1413574.
Blázquez A, Escribano-romero E, Merino-ramos T, Saiz J-C, Cosby SL. Stress responses in flavivirus-infected cells: activation of unfolded protein response and autophagy. Front Microbiol. 2014;5(266):1–7. https://doi.org/10.3389/fmicb.2014.00266.
Boonyasuppayakorn S, Reichert ED, Manzano M, Padmanabhan R. Amodiaquine, an antimalarial drug, inhibits dengue virus type 2 replication and infectivity siwaporn. Antivir Res. 2015;106:125–34. https://doi.org/10.1016/j.antiviral.2014.03.014.
Braun E, Hotter D, Koepke L, Fackler OT, Kirchhoff F, Sauter D, Sparrer KMJ. Guanylate-binding proteins 2 and 5 exert broad antiviral activity by inhibiting furin-mediated processing of viral envelope proteins. Cell Rep. 2019;27:2092–104.
Braz-De-Melo HA, Pasquarelli-do-Nascimento G, Corrêa R, das Neves Almeida R, de Oliveira Santos I, Prado PS, Picolo V, de Bem AF, Pizato N, Magalhães KG. Potential neuroprotective and anti-inflammatory effects provided by Omega-3 (DHA) against Zika virus infection in human SH-SY5Y cells. Sci Rep. 2019;9(1):1–12. https://doi.org/10.1038/s41598-019-56556-y.
Bres P, Lacan A, Diop I, Michel R, Peretti P, Vidal C. Arboviruses in Senegal. A virological survey. [French]. Bull Soc Pathol Exotique. 1963.
Briant L, Desprès P, Choumet V, Missé D. Role of skin immune cells on the host susceptibility to mosquito-borne viruses. Virology. 2014. https://doi.org/10.1016/j.virol.2014.06.023.
Brown WC, Akey DL, Konwerski JR, Tarrasch JT, Skiniotis G, Kuhn RJ, Smith JL. Extended surface for membrane association in Zika virus NS1 structure. Nat Struct Mol Biol. 2016;23(9):865–7. https://doi.org/10.1038/nsmb.3268.
Browning DJ. Hydroxychloroquine and chloroquine retinopathy. In: Hydroxychloroquine and chloroquine retinopathy; 2014. p. 35–63. https://doi.org/10.1007/978-1-4939-0597-3.
Bullard-Feibelman KM, Govero J, Zhu Z, Salazar V, Veselinovic M, Diamond MS, Geiss BJ. The FDA-approved drug sofosbuvir inhibits Zika virus infection. Antivir Res. 2017;137(January):134–40. https://doi.org/10.1016/j.antiviral.2016.11.023.
Burns TM. Guillain-Barré syndrome. Semin Neurol. 2008. https://doi.org/10.1055/s-2008-1062261.
Calvet G, Aguiarv RS, Melo AS, Sampaio SA, de Filippis I, Fabri A, Araujo ES, et al. Case report of detection of Zika virus genome in amniotic fluid of affected fetuses: association with microcephaly outbreak in Brazil. Lancet Infect Dis. 2016. https://doi.org/10.1017/CBO9781107415324.004.
Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G, Mulherkar N, Kuehne AI, et al. Ebola virus entry requires the cholesterol transporter niemann-pick C1. Nature. 2012;477(7364):340–3. https://doi.org/10.1038/nature10348.
Carneiro BM, Batista MN, Braga ACS, Nogueira ML, Rahal P. The green tea molecule EGCG inhibits Zika virus entry. Virology. 2016;496:215–18. https://doi.org/10.1016/j.virol.2016.06.012.
de Carvalho OV, Félix DM, de Mendonça LR, de Araújo CMCS, de Oliveira Franca RF, Cordeiro MT, Júnior AS, Pena LJ. The thiopurine nucleoside analogue 6-methylmercaptopurine riboside (6MMPr) effectively blocks zika virus replication. Int J Antimicrob Agents. 2017;50(6):718–25. https://doi.org/10.1016/j.ijantimicag.2017.08.016.
Cataneo AH, Depieri DK, Koishi AC, Zanluca C, Silveira GF, Bonato T, de Arruda A, Suzukawa A, et al. The citrus flavonoid naringenin impairs the in vitro infection of human cells by Zika virus. Sci Rep. 2019;9(1):16348. https://doi.org/10.1038/s41598-019-52626-3.
Cauchemez S, Besnard M, Bompard P, Dub T, Guillemette-Artur P, Eyrolle-Guignot D, Salje H, et al. Association between Zika virus and microcephaly in French polynesia, 2013–15: a retrospective study. Lancet. 2016;387(10033):2125–32. https://doi.org/10.1016/S0140-6736(16)00651-6.
Cells H, Narayanan A, Kehn-hall K, Senina S, Lundberg L, Duyne RV, Guendel I, et al. Curcumin inhibits rift valley fever virus replication in human cells. J Biol Chem. 2012;287(40):33198–214. https://doi.org/10.1074/jbc.M112.356535.
Chan J-W, Zhu Z, Chu H, Yuan S, Chik K-H, Chan C-S, Poon V-M, et al. The celecoxib derivative kinase inhibitor AR-12 (OSU-03012) inhibits Zika virus via down-regulation of the PI3K/Akt pathway and protects Zika virus-infected A129 mice: a host-targeting treatment strategy. Antivir Res. 2018;160(December):38–47. https://doi.org/10.1016/j.antiviral.2018.10.007.
Chen JC, Wang Z, Huang H, Weitz SH, Wang A, Qiu X, Baumeister MA, Uzgiris A. Infection of human uterine fibroblasts by Zika virus in vitro: implications for viral transmission in women. Int J Infect Dis. 2016. https://doi.org/10.1016/j.ijid.2016.07.015.
Chen HH, Chen CC, Lin YS, Chang PC, Zi Yi Lu, Lin CF, Chen CL, Chang CP. AR-12 suppresses dengue virus replication by down-regulation of PI3K/AKT and GRP78. Antivir Res. 2017b;142:158–168. https://doi.org/10.1016/j.antiviral.2017.02.015.
Chen L, Liu Y, Wang S, Sun J, Wang P, Xin X, Qilin LZ, Xiao G, Wang W. Antiviral activity of peptide inhibitors derived from the protein E stem against Japanese encephalitis and Zika viruses. Antivir Res. 2017a;141:140–149. https://doi.org/10.1016/j.antiviral.2017.02.009.
Chen T-Y, Chen D-Y, Wen H-W, Jun-lin Ou, Chiou S-S, Chen J-M, Wong M-L, Hsu W-l. Inhibition of enveloped viruses infectivity by curcumin. PLoS ONE. 2013;8(5):e62482. https://doi.org/10.1371/journal.pone.0062482.
Chen W-C, Simanjuntak Y, Chu L-W, Ping Y-H, Lee Y-L, Lin Y-L, Li W-S. Benzenesulfonamide derivatives as calcium/calmodulin-dependent protein kinase inhibitors and antiviral agents against dengue and Zika virus infections. J Med Chem. 2020;63:1313–27.
Chen Y, Maguire T, Hileman RE, Fromm JR, Esko JD, Linhardt RJ, Marks RM. Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate. Nat Med. 1997;3(8):866–71. https://doi.org/10.1038/nm0897-866.
Chouin-Carneiro T, Vega-Rua A, Vazeille M, Yebakima A, Girod R, Goindin D, Dupont-Rouzeyrol M, Lourenço-de-Oliveira R, Failloux AB. Differential susceptibilities of aedes aegypti and aedes albopictus from the Americas to Zika virus. PLoS Negl Trop Dis. 2016. https://doi.org/10.1371/journal.pntd.0004543.
Chuang C-H, Chiou S-J, Cheng T-l, Wang Y-T. A molecular dynamics simulation study decodes the Zika virus NS5 methyltransferase bound to SAH and RNA analogue. Sci Rep. 2018;8:6336. https://doi.org/10.1038/s41598-018-24775-4.
Clark MJ, Miduturu C, Schmidt AG, Zhu X, Pitts JD, Wang J, Potisopon S, et al. GNF-2 inhibits dengue virus by targeting Abl Kinases and the viral e protein. Cell Chem Biol. 2016;23(4):443–52. https://doi.org/10.1016/j.chembiol.2016.03.010.
Coutard B, Barral K, Selisko B, Martin B, Aouadi W, Lombardia MO, Vasseur J-J, Guillemot JC, Canard B, Decroly E. Zika virus methyltransferase: structure and functions for drug design perspectives. J Virol. 2017;91(5):1–15.
Cumberworth SL, Barrie JA, Cunningham ME, Gomes DP, de Figueiredo V, Schultz AJ, Wilder-Smith BB, et al. Zika virus tropism and interactions in myelinating neural cell cultures: CNS cells and myelin are preferentially affected. Acta Neuropathol Commun. 2017. https://doi.org/10.1186/s40478-017-0450-8.
Dai L, Song J, Xishan Lu, Deng YQ, Musyoki AM, Cheng H, Zhang Y, et al. Structures of the Zika virus envelope protein and its complex with a flavivirus broadly protective antibody. Cell Host Microbe. 2016;19(5):696–704. https://doi.org/10.1016/j.chom.2016.04.013.
Dang Y, Yonggan Wu, Jia G, Anaya E, Abraham S, Choi J, Shi G, et al. A CRISPR-based screen identifies genes essential for West Nile virus-induced cell death. Cell Rep. 2015;12(4):673–83. https://doi.org/10.1016/j.celrep.2015.06.049.A.
Delvecchio R, Higa LM, Pezzuto P, Valadão AL, Garcez PP, Monteiro FL, Loiola EC, et al. Chloroquine, an endocytosis blocking agent, inhibits Zika virus infection in different cell models. Viruses. 2016;8(12):1–15. https://doi.org/10.3390/v8120322.
Dick GWA. Zika virus (I). Isolations and serological specificity. Trans Royal Soc Trop Med Hyg. 1952. https://doi.org/10.1016/0035-9203(52)90042-4.
Dong X, Moyer MM, Yang F, Sun YP, Yang L. Carbon dots’ antiviral functions against noroviruses. Sci Rep. 2017;7(1):1–10. https://doi.org/10.1038/s41598-017-00675-x.
Duffy MR, Tai-Ho Chen W, Hancock T, Powers AM, Kool JL, Lanciotti RS, Pretrick M, et al. Zika virus outbreak on Yap Island, federated states of micronesia. N Engl J Med. 2009;360(24):2536–43. https://doi.org/10.1056/NEJMoa0805715.
Dupont-Rouzeyrol M, Biron A, O’Connor O, Huguon E, Descloux E. Infectious Zika viral particles in breastmilk. The Lancet. 2016;387(10023):1051. https://doi.org/10.1016/S0140-6736(16)00624-3.
Dutta K, Ghosh D, Basu A. Curcumin protects neuronal cells from Japanese encephalitis virus-mediated cell death and also inhibits infective viral particle formation by dysregulation of ubiquitin—proteasome system. J Neuroimmune Pharmacol. 2009;4:328–37. https://doi.org/10.1007/s11481-009-9158-2.
ECDC, Rapid Risk Assessment. Rapid risk assessment Zika virus epidemic in the Americas: potential association with microcephaly and Guillain-Barré syndrome main conclusions disease background information Zika virus disease. ECDC. 2015.
Eddowes LA, Al-hourani K, Ramamurthy N, Frankish J, Baddock HT, Sandor C, Ryan JD, et al. Antiviral activity of bone morphogenetic proteins and activins. Nat Microbiol. 2019;4:339–51. https://doi.org/10.1038/s41564-018-0301-9.
Eijk AA, Der V, Van Genderen PJ, Verdijk RM, Reusken CB, Mögling R, Van Kampen JJA, Widagdo W, et al. Miscarriage associated with Zika virus infection. N Engl J Med. 2016. https://doi.org/10.1056/NEJMc1605898.
Elfiky AA, Ismail AM. Molecular docking revealed the binding of nucleotide/side inhibitors to Zika viral polymerase solved structures. SAR QSAR Environ Res. 2018;29(5):409–18. https://doi.org/10.1080/1062936X.2018.1454981.
Españo E, Nam JH, Song EJ, Song D, Lee CK, Kim JK. Lipophilic statins inhibit Zika virus production in vero cells. Sci Rep. 2019;9(1):1–11. https://doi.org/10.1038/s41598-019-47956-1.
Fangueiro JF, Calpena AC, Clares B, Andreani T, Egea MA, Veiga FJ, Garcia ML, Silva AM, Souto EB. Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs). In vivo, in vitro and ex vivo studies. Int J Pharm. 2016;502:161–9. https://doi.org/10.1016/j.ijpharm.2016.02.039.
Farias KJ, Silva PR, Machado L, Fonseca BALD. Chloroquine inhibits dengue virus type 2 replication in vero cells but not in C6/36 cells. Sci World J. 2013;2013. https://doi.org/10.1155/2013/282734.
Ferrero DS, Ruiz-Arroyo VM, Soler N, Usón I, Guarné A, Verdaguer N. Supramolecular arrangement of the full-length Zika virus NS5. Rey FA, editor. PLOS Pathog. 2019;15(4):e1007656. https://doi.org/10.1371/journal.ppat.1007656.
Fink SL, Vojtech L, Wagoner J, Slivinski NSJ, Jackson KJ, Wang R, Khadka S, Luthra P, Basler CF, Polyak SJ. The antiviral drug arbidol inhibits Zika virus. Sci Rep. 2018;8(1):8989. https://doi.org/10.1038/s41598-018-27224-4.
Foo SS, Chen W, Chan Y, Bowman JW, Chang LC, Choi Y, Yoo JS, et al. Asian Zika virus strains target CD14+ blood monocytes and induce M2-skewed immunosuppression during pregnancy. Nat Microbiol. 2017. https://doi.org/10.1038/s41564-017-0016-3.
Ganjhu KR, Mudgal PP, Maity H, Dowarha D, Devadiga S, Nag S, Arunkumar G. Herbal plants and plant preparations as remedial approach for viral diseases. Virus Dis. 2015;26(4):225–36. https://doi.org/10.1007/s13337-015-0276-6.
Ghezzi S, Cooper L, Rubio A, Pagani I, Rosaria M, Ippolito G, Pelletier J, et al. Heparin prevents Zika virus induced-cytopathic effects in human neural progenitor cells. Antivir Res. 2017;140:13–7. https://doi.org/10.1016/j.antiviral.2016.12.023.
Giulietti M, Righetti A, Cianfruglia L, Šabanović B, Armeni T, Principato G, Piva F. To accelerate the Zika beat: candidate design for RNA interference-based therapy. Virus Res. 2018;255(August):133–40. https://doi.org/10.1016/j.virusres.2018.07.010.
Godoy AS, Lima GMA, Oliveira KIZ, Torres NU, Maluf FV, Guido RVC, Oliva G. Crystal structure of Zika virus NS5 RNA-dependent. Nat Commun. 2017;8:1–6. https://doi.org/10.1038/ncomms14764.
Gorshkov K, Shiryaev SA, Fertel S, Lin Y, Huang C. Zika virus: origins, pathological action, and treatment strategies. Front Microbiol. 2019;9 (3252). https://doi.org/10.3389/fmicb.2018.03252.
Grard G, Caron M, Mombo IM, Nkoghe D, Ondo SM, Jiolle D, Fontenille D, Paupy C, Leroy EM. Zika virus in gabon (Central Africa) - 2007: a new threat from aedes albopictus? PLoS Negl Trop Dis. 2014. https://doi.org/10.1371/journal.pntd.0002681.
Guerbois M, Fernandez-Salas I, Azar SR, Danis-Lozano R, Alpuche-Aranda CM, Leal G, Garcia-Malo IR, et al. Outbreak of Zika virus infection, Chiapas State, Mexico, 2015, and first confirmed transmission by aedes aegypti mosquitoes in the Americas. J Infect Dis. 2016;214(9):1349–56. https://doi.org/10.1093/infdis/jiw302.
Ha SD, Ham B, Mogridge J, Saftig P, Lin S, Kim SO. Cathepsin B-mediated autophagy flux facilitates the anthrax toxin receptor 2-mediated delivery of anthrax lethal factor into the cytoplasm. J Biol Chem. 2010;285(3):2120–9. https://doi.org/10.1074/jbc.M109.065813.
Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A, Luplertlop N, Perera-Lecoin M, et al. Biology of Zika virus infection in human skin cells. J Virol. 2015;89(17):8880–96. https://doi.org/10.1128/jvi.00354-15.
Hasan SS, Sevvana M, Kuhn RJ, Rossmann MG. Structural biology of Zika virus and other flaviviruses. Nat Struct Mol Biol. 2018;25(January):13–20. https://doi.org/10.1038/s41594-017-0010-8.
Hastings AK, Hastings K, Uraki R, Hwang J, Gaitsch H, Dhaliwal K, Williamson E, Fikrig E. Loss of the TAM receptor Axl ameliorates severe Zika virus pathogenesis and reduces apoptosis in microglia. IScience. 2019;13:339–50. https://doi.org/10.1016/j.isci.2019.03.003.
Hayes EB. Zika virus outside Africa. 2009;15(9):2007–10. https://doi.org/10.3201/eid1509.090442.
Hengphasatporn K, Kungwan N, Rungrotmongkol T. Binding pattern and susceptibility of epigallocatechin gallate against envelope protein homodimer of Zika virus: a molecular dynamics study. J Mol Liq. 2019;274:140–7. https://doi.org/10.1016/j.molliq.2018.10.111.
Hilgenfeld R. Zika virus NS 1, a pathogenicity factor with many faces. EMBO J. 2016;35(24):2631–33. https://doi.org/10.15252/embj.201695871.
Hitakarun A, Khongwichit S, Wikan N, Roytrakul S, Yoksan S, Rajakam S, Davidson AD, Smith DR. Evaluation of the antiviral activity of orlistat (tetrahydrolipstatin) against Dengue virus, Japanese encephalitis virus, Zika virus and Chikungunya virus. Sci Rep. 2020;10(1499). https://doi.org/10.1038/s41598-020-58468-8.
Holbrook M. Historical perspectives on flavivirus research. Viruses. 2017;9(5):97. https://doi.org/10.3390/v9050097.
Huang S, Jiangjiang Gu, Ye J, Fang B, Wan S, Wang C. Benzoxazine monomer derived carbon dots as a broad-spectrum agent to block viral infectivity. J Colloid Interface Sci. 2019;542:198–206. https://doi.org/10.1016/j.jcis.2019.02.0100021-9797.
Huang Y, Li Y, Zhang H, Zhao R, Jing R, Yinghua Xu, He M, et al. Zika virus propagation and release in human fetal astrocytes can be suppressed by neutral sphingomyelinase-2 inhibitor GW4869. Cell Discov. 2018;4(1):19. https://doi.org/10.1038/s41421-018-0017-2.
Ianevski A, Zusinaite E, Kuivanen S, Strand M, Lysvand H, Teppor M, Kakkola L, et al. Novel activities of safe-in-human broad-spectrum antiviral agents. 2018;154(April):174–82.
Iloni G, Vasam S, Guguloth V, Vadde R. One-pot multi-component synthesis of [1, 4] benzoxazine-isoxazole hybrids and their antibacterial activity. Int J Pharm Chem Biol Sci. 2018;8(1):118–24.
Irwin JJ, Shoichet BK. ZINC—a free database of commercially available compounds for virtual screening. J Chem Inf Model. 2005;45(1):177–82.
Julander JG, Siddharthan V, Evans J, Taylor R, Tolbert K, Apuli C, Stewart J, et al. Efficacy of the broad-spectrum antiviral compound BCX4430 against Zika virus in cell culture and in a mouse model. Antivir Res. 2017;137:14–22. https://doi.org/10.1016/j.antiviral.2016.11.003.
Kamiyama N, Soma R, Hidano S, Watanabe K, Umekita H, Fukuda C, Noguchi K, et al. Ribavirin inhibits Zika virus (ZIKV) replication in vitro and suppresses viremia in ZIKV-infected STAT1-deficient mice. Antivir Res. 2017;146:1–11. https://doi.org/10.1016/j.antiviral.2017.08.007.
Kang CB, Keller TH, Luo D. Zika virus protease: an antiviral drug target. Trends Microbiol. 2017;25(10):797–808. https://doi.org/10.1016/j.tim.2017.07.001.
Kazmirchuk T, Dick K, Burnside DJ, Barnes B, Moteshareie H, Hajikarimlou M, Omidi K, et al. Designing anti-Zika virus peptides derived from predicted human-Zika virus protein-protein interactions. Comput Biol Chem. 2017;71:180–7. https://doi.org/10.1016/j.compbiolchem.2017.10.011.
Ketkar H, Yang L, Wormser GP, Wang P. Lack of efficacy of ivermectin for prevention of a lethal Zika virus infection in a murine system. Diagn Microbiol Infect Dis. 2019;95(1):38–40. https://doi.org/10.1016/j.diagmicrobio.2019.03.012.
Khandelwal N, Chander Y, Dutt K, Riyesh T, Nishanth C, Sharma S, Jindal N, Tripathi BN, Barua S, Kumar N. Emetine inhibits replication of RNA and DNA viruses without generating drug-resistant virus variants. Antivir Res. 2017;144:196–204. https://doi.org/10.1016/j.antiviral.2017.06.006.
Kim B-H, Shenoy AR, Pradeep K, Bradfield CJ, MacMicking JD. IFN-inducible GTPases in host defense. Cell Host Microbe. 2012;12(4):432–44. https://doi.org/10.1016/j.chom.2012.09.007.
Kim K, Hwan K, Young H, Kook H, Sakamoto N, Cheong J. Curcumin inhibits hepatitis C virus replication via suppressing the Akt-SREBP-1 pathway. FEBS Lett. 2010;584:707–12. https://doi.org/10.1016/j.febslet.2009.12.019.
Kim SY, Koetzner CA, Payne AF, Nierode GJ, Yanlei Yu, Wang R, Barr E, et al. Glycosaminoglycan compositional analysis of relevant tissues in Zika virus pathogenesis and in vitro evaluation of heparin as an antiviral against Zika virus infection. Biochemistry. 2019;58:1155–66. https://doi.org/10.1021/acs.biochem.8b01267.
Kim SY, Zjao J, Liu X, Fraser K, Lin L, Zhang X, Zhang F, Dordick JS, Linhardt R. Interaction of Zika virus envelope protein with glycosaminoglycans. Biochemistry. 2017;56:1151–62. https://doi.org/10.1021/acs.biochem.6b01056.
King AMQ, Lefkowitz E, Adams MJ, Carstens EB. Flaviviridae-Ninth report of the international committee on taxonomy of viruses. Virus Taxon. 2012. https://doi.org/10.1016/B978-0-12-384684-6.00086-0.
Kiss R, Sandor M, Szalai FA. Http://Mcule.Com: a public web service for drug discovery. J Cheminform. 2012;4(S1):P17. https://doi.org/10.1186/1758-2946-4-s1-p17.
Kostyuchenko VA, Lim EXY, Zhang S, Fibriansah G, Ng T-S, Ooi JSG, Shi J, Lok S-M. Structure of the thermally stable Zika virus. Nature. 2016;533(7603):425–8. https://doi.org/10.1038/nature17994.
Krishnan MN, Ng A, Sukumaran B, Gilfoy FD, Uchil PD, Sultana H, Brass AL, et al. RNA interference screen for human genes associated with West Nile virus infection. Nature. 2008;11:242–5. https://doi.org/10.1016/S0213-005X(11)70040-4.
Kuivanen S, Bespalov MM, Nandania J, Ianevski A, Velagapudi V, De Brabander JK, Kainov DE, Vapalahti O. Obatoclax, saliphenylhalamide and gemcitabine inhibit Zika virus infection in vitro and differentially affect cellular signaling, transcription and metabolism. Antivir Res. 2017;139(2017):117–28. https://doi.org/10.1016/j.antiviral.2016.12.022.
Kumar D, Aarthy M, Kumar P, Singh SK, Uversky VN, Giri R. Targeting the NTPase site of Zika virus NS3 helicase for inhibitor discovery. J Biomol Struct Dyn. 2019;1102. https://doi.org/10.1080/07391102.2019.1689851.
Kusaka T, Yamamoto H, Shibata M, Muroi M, Kishi T, Mizuno K. Streptomyces citricolor Nov. SP. and a new antibiotic, aristeromycin. J Antibiot. 1968;21(4):255–63. https://doi.org/10.7164/antibiotics.21.255.
Lambert JD, Sang S, Hong J, Kwon S-J, Lee M-J, Ho C-T, Yang CS, Al LET. Peracetylation as a means of enhancing in vitro bioactivity and bioavailability of epigallocatechin-3-gallate ABSTRACT. Drug Metab Dispos. 2006;34:2111–6. https://doi.org/10.1124/dmd.106.011460.small.
Le Lee J, Loe MWC, Lee RCH, Chu JJH. Antiviral activity of pinocembrin against Zika virus replication. Antivir Res. 2019;167(March):13–24. https://doi.org/10.1016/j.antiviral.2019.04.003.
Leyssen P, De Clercq E, Neyts J. Perspectives for the treatment of infections with flaviviridae. Clin Microbiol Rev. 2000;13(1):67–82. https://doi.org/10.1128/CMR.13.1.67-82.2000.
Li C, Deng Y. 25-hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a article 25-hydroxycholesterol protects host against Zika virus infection and its associated microcephaly in a mouse model. Immunity. 2017;46:446–56. https://doi.org/10.1016/j.immuni.2017.02.012.
Li C, Zhu X, Ji X, Quanquin N, Deng YQ, Tian M, Aliyari R, et al. Chloroquine, a FDA-approved drug, prevents Zika virus infection and its associated congenital microcephaly in mice. EBio Med. 2017;24:189–94. https://doi.org/10.1016/j.ebiom.2017.09.034.
Li F, Lee EM, Sun X, Wang D, Tang H, Zhou G. Design, synthesis and discovery of andrographolide derivatives against Zika virus infection. Eur J Med Chem. 2020;187:111925. https://doi.org/10.1016/j.ejmech.2019.111925.
Li P-C, Jang J, Hsia C-Y, Groomes PV, Lian W, de Wispelaere M, Pitts JD, et al. Small molecules targeting the flavivirus E protein with broad-spectrum activity and antiviral efficacy in vivo. ACS Infect Dis. 2019;5(3):460–72. https://doi.org/10.1021/acsinfecdis.8b00322.
Lian W, Jang J, Potisopon S, Li P-C, Rahmeh A, Wang J, Kwiatkowski NP, Gray NS, Yang PL. Discovery of immunologically inspired small molecules that target the viral envelope protein. ACS Infect Dis. 2018;4:1395–406. https://doi.org/10.1021/acsinfecdis.8b00127.
Lim SP, Noble CG, Shi P-Y. The dengue virus NS5 protein as a target for drug discovery. Antivir Res. 2015;119:57–67. https://doi.org/10.1016/j.antiviral.2015.04.010.
Liu SY, Sanchez DJ, Aliyari R, Lu S, Cheng G. Systematic identification of type I and type II interferon-induced antiviral factors. PNAS. 2012;109(11):4239–44. https://doi.org/10.1073/pnas.1114981109.
Loe MW, Choy RC, Lee H, Chu JJH. Antiviral activity of the FDA-approved drug candesartan cilexetil against Zika virus infection. Antivir Res. 2019;172(June):104637. https://doi.org/10.1016/j.antiviral.2019.104637.
MacNamara FN. Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg. 1954;48(2):139–45. https://doi.org/10.1016/0035-9203(54)90006-1.
Mairiang D, Zhang H, Sodja A, Murali T, Suriyaphol P, Malasit P, Limjindaporn T, Finley RL. Identification of new protein interactions between dengue fever virus and its hosts, human and mosquito. PLoS ONE. 2013;8(1):e53535. https://doi.org/10.1371/journal.pone.0053535.
Makhluf H, Kim K, Shresta S. Novel strategies for discovering inhibitors of dengue and Zika fever. Expert Opin Drug Discov. 2016;11(10):921–3. https://doi.org/10.1080/17460441.2016.1212013.
Marchette NJ, Garcia R, Rudnick A. Isolation of Zika virus from aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg. 1969. https://doi.org/10.4269/ajtmh.1969.18.411.
Martín-Acebes MA, Vázquez-Calvo Á, Saiz J-C. Lipids and flaviviruses, present and future perspectives for the control of Dengue, Zika, and West Nile viruses. Prog Lipid Res. 2016;64:123–37. https://doi.org/10.1016/j.plipres.2016.09.005.
Martinez-Lopez A, Persaud M, Puray M, Zhang H, Rong L, Liu S, Wang TT, Sara SG, Diaz-griffero F. Glycosylated diphyllin as a broad-spectrum antiviral agent against Zika virus. EBio Med. 2019;47:269–83. https://doi.org/10.1016/j.ebiom.2019.08.060.
Mazumder A, Raghavan K, Weinstein J, Kohn KW, Pommier Y. Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochem Pharmacol. 1995;49(8):1165–70.
Meertens L, Labeau A, Dejarnac O, Cipriani S, Sinigaglia L, Bonnet-Madin L, Le Charpentier T, et al. Axl mediates ZIKA virus entry in human glial cells and modulates innate immune responses. Cell Rep. 2017;18(2):324–33. https://doi.org/10.1016/j.celrep.2016.12.045.
Miner JJ, Diamond MS. Zika virus pathogenesis and tissue tropism. Cell Host Microbe. 2017;21(2):134–42. https://doi.org/10.1016/j.chom.2017.01.004.
Mlakar J, Korva M, Tul N, Popović M, Poljšak-Prijatelj M, Mraz J, Kolenc M, et al. Zika virus associated with microcephaly. N Engl J Med. 2016;374(10):951–8. https://doi.org/10.1056/NEJMoa1600651.
Moghadasian MH. Clinical pharmacology of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Life Sci. 1999;65(13):1329–37. https://doi.org/10.1016/S0024-3205(99)00199-X.
Mohr EL, McMullan LK, Lo MK, Spengler JR, Bergeron É, Albariño CG, Shrivastava-Ranjan P, et al. Inhibitors of cellular kinases with broad-spectrum antiviral activity for hemorrhagic fever viruses. Antivir Res. 2015;120:40–7. https://doi.org/10.1016/j.antiviral.2015.05.003.
Montes-Grajales D, Puerta-Guardo H, Espinosa DA, Harris E, Caicedo-Torres W, Olivero-Verbel J, Martínez-Romero E. In silico drug repurposing for the identification of potential candidate molecules against arboviruses infection. Antivir Res. 2020;173(November 2019):104668. https://doi.org/10.1016/j.antiviral.2019.104668.
Morcos PA, Li Y, Jiang S. Vivo-Morpholinos: a non-peptide transporter delivers morpholinos into a wide array of mouse tissues short technical reports. Biotechniques. 2008;45:613–23. https://doi.org/10.2144/000113005.
Moreira J, Peixoto TM, Siqueira AM, Lamas CC. Sexually acquired Zika virus: a systematic review. Clin Microbiol Infect. 2017;23(5):296–305. https://doi.org/10.1016/j.cmi.2016.12.027.
Motta IJF, Spencer BR, Suely G, da Silva C, Arruda MB, Dobbin JA, Gonzaga YBM, Arcuri IP, et al. Evidence for transmission of Zika virus by platelet transfusion. N Engl J Med. 2016;375(11):1101–3. https://doi.org/10.1056/NEJMc1607262.
Moulton JD, Shan J. Gene knockdowns in adult animals: PPMOs and vivo-morpholinos. Molecules. 2009;14(3):1304–23. https://doi.org/10.3390/molecules14031304.
Mounce BC, Cesaro T, Carrau L, Vallet T, Vignuzzi M. Curcumin inhibits Zika and Chikungunya virus infection by inhibiting cell binding. Antivir Res. 2017;142:148–57. https://doi.org/10.1016/j.antiviral.2017.03.014.
Müller JA, Harms M, Krüger F, Groß R, Joas S, Hayn M, Dietz AN, et al. Semen inhibits Zika virus infection of cells and tissues from the anogenital region. Nat Commun. 2018;9(1):2207. https://doi.org/10.1038/s41467-018-04442-y.
Musso D, Roche C, Robin E, Nhan T, Teissier A, Cao-Lormeau V-M. Potential sexual transmission of Zika virus. Emerg Infect Dis. 2015;21(2):359–61. https://doi.org/10.3201/eid2102.141363.
Neris RLS, Figueiredo CM, Higa LM, Araujo DF, Carvalho CAM, Verçoza BRF, Silva MOL, et al. Co-protoporphyrin IX and Sn-protoporphyrin IX inactivate Zika, Chikungunya and other arboviruses by targeting the viral envelope. Sci Rep. 2018;8:9805. https://doi.org/10.1038/s41598-018-27855-7.
Nitsche C. Proteases from Dengue, West Nile and Zika viruses as drug targets. Biophys Rev. 2019;11(2):157–65. https://doi.org/10.1007/s12551-019-00508-3.
Oliveira Melo AS, Malinger G, Ximenes R, Szejnfeld PO, Alves Sampaio S, Bispo de Filippis AM. Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg? Ultrasound Obstet Gynecol. 2016;47(1):6–7. https://doi.org/10.1002/uog.15831.
Olson JG, Ksiazek TG, Suhandiman G, Triwibowo V. Zika virus, a cause of fever in central Java, Indonesia. Trans R Soc Trop Med Hyg. 1981. https://doi.org/10.1016/0035-9203(81)90100-0.
Onawole AT, Sulaiman KO, Adegoke RO, Kolapo TU. Identification of potential inhibitors against the Zika virus using consensus scoring. J Mol Graph Modell. 2017;73:54–61. https://doi.org/10.1016/j.jmgm.2017.01.018.
Palanichamy K, Joshi A, Tugba Mehmetoglu-gurbuz M, Bravo F, Shlain MA, Schiro F, Naeem Y, Garg H, Braunschweig AB. Anti-Zika activity of a library of synthetic carbohydrate receptors. J Med Chem. 2019;62:4110–9. https://doi.org/10.1021/acs.jmedchem.9b00142.
Pan American Health Organisation. Neurological syndrome, congenital malformations, and Zika virus infection. Implications for Public Health in the Americas. Pan American Health Organization. 2015.
Pattnaik A, Palermo N, Sahoo BR, Yuan Z, Duoyi Hu, Annamalai AS, Vu HLX, et al. Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening. Antivir Res. 2018;151:78–86. https://doi.org/10.1016/j.antiviral.2017.12.016.
Persaud M, Martinez-lopez A, Cindy Bu, Porcelli SA, Diaz-gri F. Infection by Zika viruses requires the transmembrane protein AXL, endocytosis and low PH. Virology. 2018;518:301–12. https://doi.org/10.1016/j.virol.2018.03.009.
Phoo WW, Zhang Z, Wirawan M, Chew EJC, Chew ABL, Kouretova J, Steinmetzer T, Luo D. Structures of Zika virus NS2B-NS3 protease in complex with peptidomimetic inhibitors. Antivir Res. 2018;160(August):17–24. https://doi.org/10.1016/j.antiviral.2018.10.006.
Pitts JD, Li P-C, De Wispelaere M, Yang PL. Antiviral activity of N-(4-hydroxyphenyl) retinamide (4-HPR) against Zika virus. Antivir Res. 2017;147:124–30. https://doi.org/10.1016/j.antiviral.2017.10.014.
Popik W, Khatua A, Hildreth JEK, Lee B, Alcendor DJ. Phosphorodiamidate morpholino targeting the 5′ untranslated region of the ZIKV RNA inhibits virus replication. Virology. 2018;519(April):77–85. https://doi.org/10.1016/j.virol.2018.04.001.
Prasad VM, Miller AS, Klose T, Sirohi D, Buda G, Jiang W, Kuhn RJ, Rossmann MG. Structure of the immature Zika virus at 9 Å resolution. Nat Struct Mol Biol. 2017;24(2):184–6. https://doi.org/10.1038/nsmb.3352.
Priya S, Senthil KN, Hemalatha S. Antiviral phytocompounds target envelop protein to control Zika virus. Comput Biol Chem. 2018;77:402–12. https://doi.org/10.1016/j.compbiolchem.2018.08.008.
Quek JP, Liu S, Zhang Z, Li Y, Yihui E, Ying Ru, Hung AW, Luo D, Kang C. Identification and structural characterization of small molecule fragments targeting Zika virus NS2B-NS3 protease. Antivir Res. 2020;175:104707. https://doi.org/10.1016/j.antiviral.2020.104707.
Quintana VM, Selisko B, Brunetti JE, Eydoux C, Guillemot JC, Canard B, Damonte EB, Julander JG, Castilla V. Antiviral activity of the natural alkaloid anisomycin against Dengue and Zika viruses. Antivir Res. 2020;176(January):104749. https://doi.org/10.1016/j.antiviral.2020.104749.
Ramharack P, Soliman MES. Zika virus NS5 protein potential inhibitors: an enhanced in silico approach in drug discovery. J Biomol Struct Dyn. 2018;36(5):1118–33. https://doi.org/10.1080/07391102.2017.1313175.
Rattanaburee T, Junking M, Panya A, Sawasdee N, Songprakhon P, Suttitheptumrong A, Limjindaporn T, Haegeman G, Yenchitsomanus PT. Inhibition of Dengue virus production and cytokine/chemokine expression by Ribavirin and compound A. Antivir Res. 2015;124:83–92. https://doi.org/10.1016/j.antiviral.2015.10.005.
Rausch K, Hackett BA, Weinbren NL, Reeder SM, Sadovsky Y, Hunter CA, Schultz DC, Coyne CB, Cherry S. Screening bioactives reveals nanchangmycin as a broad spectrum antiviral active against Zika virus. Cell Rep. 2017;18(3):804–15. https://doi.org/10.1016/j.celrep.2016.12.068.
Reis RAG, Calil FA, Feliciano PR, Pinheiro MP, Cristina Nonato M. The dihydroorotate dehydrogenases: past and present. Arch Biochem Biophys. 2017;632:175–91. https://doi.org/10.1016/j.abb.2017.06.019.
Renaudet J, Jan C, Ridet J, Adam C, Robin Y. Enquête Sérologique Pour Les Arbovirus Dans La Population Humaine Du Sénégal. A serological survey of arboviruses in the human population of senegal. Bull Soc Pathol Exotique Ses Filiales. 1978.
Richard AS, Shim B-S, Kwon Y-C, Zhang R, Otsuka Y, Schmitt K, Berri F, Diamond MS, Choe H. AXL-dependent infection of human fetal endothelial cells distinguishes Zika virus from other pathogenic flaviviruses. Proc Natl Acad Sci. 2017;114(8):2024–9. https://doi.org/10.1073/pnas.1620558114.
Rieth S, Miner MR, Chang CM, Hurlocker B, Braunschweig AB. Saccharide receptor achieves concentration dependent mannoside selectivity through two distinct cooperative binding pathways. Chem Sci. 2013;4:357–67. https://doi.org/10.1039/c2sc20873c.
Robin Y, Mouchet J. A serologic and entomologic survey on yellow fever in Sierra Leone. Bull Soc Pathol Exotique Ses Filiales. 1975.
Röcker AE, Müller JA, Dietzel E, Harms M, Krüger F, Heid C, Sowislok A, et al. The molecular Tweezer CLR01 inhibits Ebola and Zika virus infection. Antivir Res. 2018;152(April):26–35. https://doi.org/10.1016/j.antiviral.2018.02.003.
Rothan HA, Zhong Y, Sanborn MA, Teoh TC, Ruan J, Yusof R, Hang J, Henderson MJ, Fang S. Small molecule Grp94 inhibitors block Dengue and Zika virus replication. Antivir Res. 2019;171(November):104590. https://doi.org/10.1016/j.antiviral.2019.104590.
Ruan J, Rothan HA, Zhong Y, Yan W, Henderson MJ, Chen F, Fang S. A small molecule inhibitor of ER-to-cytosol protein dislocation exhibits anti-Dengue and anti-Zika virus activity. 2019;July:1–12.
Ryan JD, Ryan E, Fabre A, Lawless MW, Crowe J. Defective bone morphogenic protein signaling underlies hepcidin deficiency in HFE hereditary hemochromatosis. Hepatology. 2010;52(4):1266–73. https://doi.org/10.1002/hep.23814.
Saavedra LM, Romanelli GP, Rozo CE, Duchowicz PR. The quantitative structure-insecticidal activity relationships from plant derived compounds against Chikungunya and Zika aedes aegypti (diptera: culicidae) vector. Sci Total Environ. 2018;610–611(January):937–43. https://doi.org/10.1016/j.scitotenv.2017.08.119.
Sacramento CQ, de Melo GR, de Freitas CS, Rocha N, Hoelz LVB, Miranda M, Fintelman-Rodrigues N, et al. The clinically approved antiviral drug sofosbuvir inhibits Zika virus replication. Sci Rep. 2017;7(1):40920. https://doi.org/10.1038/srep40920.
Samsa MM, Mondotte JA, Iglesias NG, Assunção-Miranda I, Barbosa-Lima G, Da Poian AT, Bozza PT, Gamarnik AV. Dengue virus capsid protein usurps lipid droplets for viral particle formation. PLoS Pathog. 2009;5(10). https://doi.org/10.1371/journal.ppat.1000632.
Santos FRS, Nunes DAF, Lima WG, Davyt D, Santos LL, Taranto AG, Jaqueline Ferreira MS. Identification of Zika virus NS2B-NS3 protease inhibitors by structure-based virtual screening and drug repurposing approaches. J Chem Inf Model. 2020b;60(2):731–737. https://doi.org/10.1021/acs.jcim.9b00933.
Santos FRS, Lima WG, Maia EHB, Assis C, Davyt D, Taranto AG, Ferreira JMS. Identification of a potential Zika virus inhibitor targeting NS5 methyltransferase using virtual screening and molecular dynamics simulations. J Chem Inform Model. 2020a. https://doi.org/10.1021/acs.jcim.9b00809.
Sarukhanyan E, Shityakov S, Dandekar T. In silico designed Axl receptor blocking drug candidates against Zika virus infection. ACS Omega. 2018;3(5):5281–90. https://doi.org/10.1021/acsomega.8b00223.
Scaturro P, Stukalov A, Haas DA, Cortese M, Draganova K, Płaszczyca A, Bartenschlager R, Götz M, Pichlmair A. An orthogonal proteomic survey uncovers novel Zika virus host factors. Nature. 2018;561(7722):253–7. https://doi.org/10.1038/s41586-018-0484-5.
Schmaljohn AL, McClain D. Alphaviruses (togaviridae) and flaviviruses (flaviviridae). Med Microbiol. 1996.
Schmidt AG, Lee K, Yang PL, Harrison SC. Small-molecule inhibitors of dengue-virus entry. PLoS Pathog. 2012;8(4). https://doi.org/10.1371/journal.ppat.1002627.
Šebera J, Dubankova A, Sychrovský V, Ruzek D, Boura E, Nencka R. The structural model of Zika virus RNA-dependent RNA polymerase in complex with RNA for rational design of novel nucleotide inhibitors. Sci Rep. 2018;8(1):11132. https://doi.org/10.1038/s41598-018-29459-7.
Sevvana M, Long F, Miller AS, Klose T, Buda G, Sun L, Kuhn RJ, Rossmann MG. Refinement and analysis of the mature Zika virus cryo-EM structure at 3.1 Å resolution. Structure. 2018;26(9):1169–1177.e3. https://doi.org/10.1016/j.str.2018.05.006.
Shang Z, Song H, Shi Yi, Qi J, Gao GF. Crystal structure of the capsid protein from Zika virus. J Mol Biol. 2018;430(7):948–62. https://doi.org/10.1016/j.jmb.2018.02.006.
Sharma N, Murali A, Singh SK, Giri R. Epigallocatechin gallate, an active green tea compound inhibits the Zika virus entry into host cells via binding the envelope protein. Int J Biol Macromol. 2017;104:1046–54. https://doi.org/10.1016/j.ijbiomac.2017.06.105.
Shi Y, Gao GF. Structural biology of the Zika virus. Trends Biochem Sci. 2017;42(6):443–56. https://doi.org/10.1016/j.tibs.2017.02.009.
Shiryaev SA, Mesci P, Pinto A, Fernandes I, Sheets N, Shresta S, Farhy C, et al. Repurposing of the anti-Malaria drug chloroquine for Zika virus treatment and prophylaxis. Sci Rep. 2017;7(15771). https://doi.org/10.1038/s41598-017-15467-6.
Si X, Wang Y, Wong J, Zhang J, Mcmanus BM, Luo H. Dysregulation of the ubiquitin-proteasome system by curcumin suppresses coxsackievirus B3 replication. J Virol. 2007;81(7):3142–50. https://doi.org/10.1128/JVI.02028-06.
da Silva-Júnior EF, Leoncini GO, Rodrigues ÉES, Aquino TM, Araújo-Júnior JX. The medicinal chemistry of Chikungunya virus. Bioorg Med Chem. 2017;25(16):4219–44. https://doi.org/10.1016/j.bmc.2017.06.049.
da Silva-Júnior EF, de Araújo-Júnior JX. Peptide derivatives as inhibitors of NS2B-NS3 protease from Dengue, West Nile, and Zika flaviviruses. Bioorg Med Chem. 2019;27(18):3963–78. https://doi.org/10.1016/j.bmc.2019.07.038.
da Silva-Júnior EF, Schirmeister T, Araújo-Júnior JX. Recent advances in inhibitors of flavivirus NS2B-NS3 protease from Dengue, Zika, and West Nile viruses. In: Vector-borne diseases and treatment; 2018. p. 1–25.
Simanjuntak Y, Liang JJ, Lee YL, Lin YL. Japanese encephalitis virus exploits dopamine D2 receptor-phospholipase C to target dopaminergic human neuronal cells. Front Microbiol. 2017;8(April):1–12. https://doi.org/10.3389/fmicb.2017.00651.
Singh A, Jana NK. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening. Comput Biol Chem. 2017;71:144–51. https://doi.org/10.1016/j.compbiolchem.2017.10.007.
Singh PK, Singh S, Farr D, Kumar A. Interferon-stimulated gene 15 (ISG15) restricts Zika virus replication in primary human corneal epithelial cells. Ocular Surf. 2019;17(3):551–9. https://doi.org/10.1016/j.jtos.2019.03.006.
Sinigaglia A, Riccetti S, Trevisan M, Barzon L. In silico approaches to Zika virus drug discovery. Expert Opin Drug Discov. 2018;13(9):825–35. https://doi.org/10.1080/17460441.2018.1515909.
Sintchak MD, Nimmesgern E. The structure of inosine 5’-monophosphate dehydrogenase and the design of novel inhibitors. Immunopharmacology. 2000;47(2–3):163–84. https://doi.org/10.1016/S0162-3109(00)00193-4.
Sirohi D, Chen Z, Sun L, Tomas Klose TC, Pierson MG, Rossmann, R. J. Kuhn. The 3.8 Å resolution cryo-EM structure of Zika virus. Science. 2016;352(6284):467–70. https://doi.org/10.1126/science.aaf5316.
Sirohi D, Kuhn RJ. Zika virus structure, maturation, and receptors. J Infect Dis. 2017;216(Suppl_10):S935–44. https://doi.org/10.1093/infdis/jix515.
Sørensen MG, Henriksen K, Neutzsky-wulff AV, Dziegiel MH, Karsdal MA. Diphyllin, a novel and naturally potent V-ATPase inhibitor, abrogates acidification of the osteoclastic resorption lacunae and bone resorption. J Bone Miner Res. 2007;22(10):1640–8. https://doi.org/10.1359/JBMR.070613.
Stadler K, Allison SL, Schalich J, Heinz FX. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol. 1997;71(11):8475–81. https://doi.org/10.1128/JVI.71.11.8475-8481.1997.
Steinmann J, Buer J, Pietschmann T, Steinmann E. Anti-infective properties of (EGCG), a component of green tea. Br J Pharmacol. 2013;168:1059–73. https://doi.org/10.1111/bph.12009.
Low SY, June, Chen KC, Wu KX, Ng MM-L, Chu JJH. Antiviral activity of emetine dihydrochloride against dengue virus infection. J Antivir Antiretrovir. 2009;01(01):062–071. https://doi.org/10.4172/jaa.1000009.
Sun J, Niu Y, Wang C, Zhang H, Xie B, Fengrong Xu, Jin H, Peng Y, Liang L, Ping Xu. Discovery of 3-benzyl-1,3-benzoxazine-2,4-dione analogues as allosteric mitogen-activated kinase kinase (MEK) inhibitors and anti-enterovirus 71 (EV71) agents. Bioorg Med Chem. 2016;24(16):3472–82. https://doi.org/10.1016/j.bmc.2016.05.055.
Surnar B, Kamran MZ, Shah AS, Basu U, Kolishetti N, Deo S, Jayaweera DT, Daunert S, Dhar S. Orally administrable therapeutic synthetic nanoparticle for Zika virus. ACS Nano. 2019;13(10):11034–48. https://doi.org/10.1021/acsnano.9b02807.
Suroengrit A, Yuttithamnon W, Srivarangkul P, Pankaew S. Halogenated chrysins inhibit Dengue and Zika virus infectivity. Sci Rep. 2017;7(13696). https://doi.org/10.1038/s41598-017-14121-5.
Tan TY, Fibriansah G, Kostyuchenko VA, Ng TS, Lim XX, Zhang S, Lim XN, et al. Capsid protein structure in Zika virus reveals the flavivirus assembly process. Nat Commun. 2020;11(1):1–13. https://doi.org/10.1038/s41467-020-14647-9.
Tao Z, Cao R, Yan Y, Huang G, Lv K, Li W, Geng Y, et al. Design, synthesis and in vitro anti-Zika virus evaluation of novel sinefungin derivatives. Eur J Med Chem. 2018;157:994–1004. https://doi.org/10.1016/j.ejmech.2018.08.057.
Tian H, Ji X, Yang X, Xie W, Yang K, Chen C, Chen Wu, et al. The crystal structure of Zika virus helicase: basis for antiviral drug design. Protein Cell. 2016;7(6):450–4. https://doi.org/10.1007/s13238-016-0275-4.
Ting Du, Dong N, Fang L, Jian Lu, Bi J, Xiao S, Han H. Multisite inhibitors for enteric coronavirus: antiviral cationic carbon dots based on curcumin. ACS Appl Nano Mater. 2018;1(10):5451–9. https://doi.org/10.1021/acsanm.8b00779.
Tognarelli J, Ulloa S, Villagra E, Lagos J, Aguayo C, Fasce R, Parra B, et al. A report on the outbreak of Zika virus on Easter Island, South Pacific, 2014. Adv Virol. 2016. https://doi.org/10.1007/s00705-015-2695-5.
Tong X, Smith J, Bukreyeva N, Koma T, Manning JT, Kalkeri R, Kwong AD, Paessler S. Merimepodib, an IMPDH inhibitor, suppresses replication of Zika virus and other emerging viral pathogens. Antivir Res. 2018;149:34–40. https://doi.org/10.1016/j.antiviral.2017.11.004.
Upadhyay AK, Cyr M, Longenecker K, Tripathi R, Sun C, Kempf DJ. Crystal structure of full-length Zika virus NS5 protein reveals a conformation similar to Japanese encephalitis virus NS5. Acta Crystallogr Sect F Struct Biol Commun. 2017;73:116–22. https://doi.org/10.1107/S2053230X17001601.
Vasireddi M, Crum A, May H, Katz D, Hilliard J. A novel antiviral inhibits Zika virus infection while increasing intracellular glutathione biosynthesis in distinct cell culture models. Antivir Res. 2019;161:46–52. https://doi.org/10.1016/j.antiviral.2018.09.004.
Vassiliou AG, Maniatis NA, Orfanos SE, Mastora Z, Jahaj E, Paparountas T, Armaganidis A, Roussos C, Aidinis V, Kotanidou A. Induced expression and functional effects of aquaporin-1 in human leukocytes in sepsis. Crit Care. 2013;17(R199). https://doi.org/10.1186/cc12893.
Vestal DJ, Jeyaratnam JA. The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase. J Interferon Cytokine Res. 2011;31(1):89–97. https://doi.org/10.1089/jir.2010.0102.
Voss S, Nitsche C. Inhibitors of the Zika virus protease NS2B-NS3. Bioorg Med Chem Lett. 2020;30(5):126965. https://doi.org/10.1016/j.bmcl.2020.126965.
Wang H, Li Z, Niu J, Xu Y, Ma L, Lu A, Wang X, et al. Antiviral effects of ferric ammonium citrate. Cell Discov. 2018;4(14). https://doi.org/10.1038/s41421-018-0013-6.
Warren TK, Wells J, Panchal RG, Stuthman KS, Garza NL, Van Tongeren SA, Dong L, et al. Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430. Nature. 2014;508:402–5. https://doi.org/10.1038/nature13027.
de Wispelaere M, Lian W, Potisopon S, Li PC, Jang J, Ficarro SB, Clark MJ, et al. Inhibition of flaviviruses by targeting a conserved pocket on the viral envelope protein. Cell Chem Biol. 2018;25(8):1006-1016.e8. https://doi.org/10.1016/j.chembiol.2018.05.011.
Xu M, Lee EM, Wen Z, Cheng Y, Huang WK, Qian X, Tcw J, et al. Identification of small-molecule inhibitors of Zika virus infection and induced neural cell death via a drug repurposing screen. Nat Med. 2016;22(10):1101–7. https://doi.org/10.1038/nm.4184.
Yadav R, Selvaraj C, Aarthy M, Kumar P, Kumar A, Singh SK, Giri R. Investigating into the molecular interactions of flavonoids targeting NS2B-NS3 protease from ZIKA virus through in-silico approaches. J Biomol Struct Dyn. 2020:1–13. https://doi.org/10.1080/07391102.2019.1709546.
Yamaguchi K, Honda M, Ikigai H, Hara Y. Inhibitory effects of (−)-epigallocatechin gallate on the life cycle of human immunodeficiency virus type 1 (HIV-1). Antivir Res. 2002;53:19–34.
Yang CF, Gopula B, Liang JJ, Li JK, Chen SY, Lee YL, Chen CS, Lin YL. Novel AR-12 derivatives, P12–23 and P12–34, inhibit flavivirus replication by blocking host de novo pyrimidine biosynthesis. Emerg Microbes Infect. 2018a;7(1):187. https://doi.org/10.1038/s41426-018-0191-1.
Yang S, Xu M, Lee EM, Gorshkov K, Shiryaev SA, He S, Sun W, et al. Emetine inhibits Zika and Ebola virus infections through two molecular mechanisms: inhibiting viral replication and decreasing viral entry. Cell Discov. 2018b;4(31). https://doi.org/10.1038/s41421-018-0034-1.
Yang J, Xu Y, Yan Y, Li W, Zhao L, Dai Q, Li Y, et al. Small molecule inhibitor of ATPase activity of HSP70 as a broad-spectrum inhibitor against flavivirus infections. ACS Infect Dis. 2020. acsinfecdis.9b00376. https://doi.org/10.1021/acsinfecdis.9b00376.
Yang Y, Cao L, Gao H, Yue Wu, Wang Y, Fang F, Lan T, Lou Z, Rao Yu. Discovery, optimization, and target identification of novel potent broad-spectrum antiviral inhibitors. J Med Chem. 2019;62:4056–73. https://doi.org/10.1021/acs.jmedchem.9b00091.
Yang Y, Yu Y, Li X, Li J, Wu Y, Yu J, Ge J, et al. Target elucidation by cocrystal structures of NADH-ubiquinone oxidoreductase of plasmodium falciparum (Pf NDH2) with small molecule to eliminate drug-resistant Malaria. 2017. https://doi.org/10.1021/acs.jmedchem.6b01733.
Yebra MJ, Sanchez J, Martin CG, Hardisson C, Barbes C. The effect of sinefungin and synthetic analogues on RNA and DNA methyltransferases from streptomyces. J Antibiot. 1991;44(10):1141–7. https://doi.org/10.7164/antibiotics.44.1141.
Yin Z, Chen YL, Schul W, Wang QY, Feng Gu, Duraiswamy J, Kondreddi RR, et al. An adenosine nucleoside inhibitor of Dengue virus. PNAS. 2009;106(48):20435–9. https://doi.org/10.1073/pnas.0907010106.
Yoon J-S, Kim G, Jarhad DB, Kim H-R, Shin Y-S, Shuhao Qu, Sahu PK, et al. Design, synthesis, and anti-RNA virus activity of 6′-fluorinated-aristeromycin analogues. J Med Chem. 2019;63:6346–62. https://doi.org/10.1021/acs.jmedchem.9b00781.
Yuan S, Cao S, Jiang R, Liu R, Bai J, Hou Qi. FLLL31, a derivative of curcumin, attenuates airway in Fl ammation in a multi-allergen challenged mouse model. Int Immunopharmacol. 2014;21:128–36. https://doi.org/10.1016/j.intimp.2014.04.020.
Zanluca C, Campos V, De Melo A, Luiza A, Mosimann P, Igor G, Nunes C, Luz K. First report of autochthonous transmission of Zika virus in Brazil. 2015;110(June):569–72. https://doi.org/10.1590/0074-02760150192.
Zhang S, Yi C, Li C, Zhang F, Peng J, Wang Q, Liu X, et al. Chloroquine inhibits endosomal viral RNA release and autophagy-dependent viral replication and e Ff ectively prevents maternal to fetal transmission of Zika virus. Antivir Res. 2019;169:104547. https://doi.org/10.1016/j.antiviral.2019.104547.
Zhang Z, Li Y, Loh YR, Phoo WW, Hung AW, Kang CongBao, Luo D. Crystal structure of unlinked NS2B-NS3 protease from Zika virus. Science. 2016;354(6319):1597–600. https://doi.org/10.1126/science.aai9309.
Zhong Y, Fang S. Live cell imaging of protein dislocation from the endoplasmatic reticulum. J Biol Chem. 2012;287(33):28057–66. https://doi.org/10.1074/jbc.M112.381798.
Zhu S, Zhang C, Huang LS, Zhang XQ, Xu Y, Fang X, Zhou J, et al. Discovery and computational analyses of novel small molecule Zika virus inhibitors. Molecules. 2019;24(8). https://doi.org/10.3390/molecules24081465.
Zhu Y-Z, Xu Q-Q, Wu D-G, Ren H, Zhao P, Lao W-G, Wang Y, et al. Japanese encephalitis virus enters rat neuroblastoma cells via a PH-dependent, dynamin and caveola-mediated endocytosis pathway. J Virol. 2012;86(24):13407–22. https://doi.org/10.1128/JVI.00903-12.
Zilbermintz L, Leonardi W, Jeong S, Sjodt M, Mccomb R, Ho CC, Retterer C, Gharaibeh D, Zamani R, Soloveva V. Identification of agents effective against multiple toxins and viruses by host-oriented cell targeting. Sci. Rep. 2015;5(13476). https://doi.org/10.1038/srep13476.
Acknowledgements
The authors thank the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brazil (CAPES), Fundação de Amparo à Pesquisa do Estado de Alagoas (FAPEAL), and the National Council for Scientific and Technological Development (CNPq)—Brazil for their support to the Brazilian Post-Graduate Programs. The authors also acknowledge the website https://smart.servier.com, which was used to generate the Fig. 2 in this chapter.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties.
Rights and permissions
Copyright information
© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Rodrigues, É.E.S. et al. (2021). The Medicinal Chemistry of Zika Virus. In: Ahmad, S.I. (eds) Human Viruses: Diseases, Treatments and Vaccines . Springer, Cham. https://doi.org/10.1007/978-3-030-71165-8_13
Download citation
DOI: https://doi.org/10.1007/978-3-030-71165-8_13
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-71164-1
Online ISBN: 978-3-030-71165-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)